EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Effects of switching from MiniMed ™ 640G to 770G on continuous glucose monitoring metrics and DTR ‐ QOL scores: An observational study of Japanese people with type 1 diabetes mellitus

Toshiki Kogai, Junko Sato iD, Haruna Yasuda, Tatsuhiro Ayame, Azusa Ozaki, Eri Takagi, Mami Koshibu, Yuya Nishida, Fuki Ikeda, Hirotaka Watada iD

Journal of Diabetes Investigation · 2025

DOI: 10.1111/jdi.14350 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Diabetes Investigation, 2025. Verfasst von Toshiki Kogai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Quality of Life, Blood Glucose Self-Monitoring, Blood Glucose. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Introduction We evaluated the effect of the MiniMed™ 770G, an insulin pump using hybrid closed‐loop technology, on blood glucose management and quality of life in Japanese people with type 1 diabetes. Materials and Methods This was a 52‐week, prospective, observational study. Fifty Japanese people with type 1 diabetes switched from the MiniMed™ 640G to 770G, and we analyzed the continuous glucose monitoring data of 24 subjects who used auto mode throughout the study. We also analyzed the scores of the Diabetes Therapy‐Related Quality of Life questionnaire completed by 26 auto‐mode users before and after the treatment change. Results The baseline time in range 70–180 mg/dL was 67.3 (54.8–78.4)%, with a significant improvement beginning 8 weeks after the switch and lasting until 52 weeks. The baseline time below range

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Quality of LifeBlood Glucose Self-MonitoringBlood GlucoseInsulin Infusion SystemsInsulinHumansFemaleMaleAdultProspective StudiesJapanMiddle AgedHypoglycemic AgentsSurveys and QuestionnairesFollow-Up StudiesYoung AdultPrognosisContinuous Glucose MonitoringEast Asian People

Stichwörter der Autor:innen

Hybrid closed‐loop systemJapaneseType 1 diabetes

Substanzen

Blood GlucoseInsulinHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.

ORCID-Profile: Junko Sato, Hirotaka Watada

Zitieren

APA

Kogai, T., Sato, J., Yasuda, H., Ayame, T., Ozaki, A., Takagi, E., Koshibu, M., Nishida, Y., Ikeda, F., & Watada, H. (2025). Effects of switching from MiniMed ™ 640G to 770G on continuous glucose monitoring metrics and DTR ‐ QOL scores: An observational study of Japanese people with type 1 diabetes mellitus. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14350

Vancouver

Kogai T, Sato J, Yasuda H, Ayame T, Ozaki A, Takagi E, et al. Effects of switching from MiniMed ™ 640G to 770G on continuous glucose monitoring metrics and DTR ‐ QOL scores: An observational study of Japanese people with type 1 diabetes mellitus. Journal of Diabetes Investigation. 2025. doi:10.1111/jdi.14350

BibTeX
@article{Kogai2025,
  author = {Kogai, Toshiki and Sato, Junko and Yasuda, Haruna and Ayame, Tatsuhiro and Ozaki, Azusa and Takagi, Eri and Koshibu, Mami and Nishida, Yuya and Ikeda, Fuki and Watada, Hirotaka},
  title = {Effects of switching from MiniMed ™ 640G to 770G on continuous glucose monitoring metrics and DTR ‐ QOL scores: An observational study of Japanese people with type 1 diabetes mellitus},
  journal = {Journal of Diabetes Investigation},
  year = {2025},
  doi = {10.1111/jdi.14350}
}
Kostenlos starten →